Ana Carolina Maldonado da Costa e Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ana Carolina Maldonado da Costa e Silva has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alex Luiz Pereira
Biosciences and Health Laboratory, Department of Biosciences, State University of Minas Gerais, Passos 37900-004, Brazil
1 shared publication - Giulia Maria Camara Leme
Post Graduate Program in Biotechnology, University of Ribeirão Preto, Ribeirão Preto 14096-900, Brazil
1 shared publication - Isabela Cristina Gomes Honório
UEMG/ Coordenadora do Curso de Engenharia Agronômica
1 shared publication - Jhuan Luiz Silva
Post Graduate Program in Health Promotion, University of Franca, Franca 14404-600, Brazil
1 shared publication - Juliana da Silva Coppede
Universidade de Ribeirão Preto
1 shared publication - Luiz Henrique Cruz
Biosciences and Health Laboratory, Department of Biosciences, State University of Minas Gerais, Passos 37900-004, Brazil
1 shared publication
Latest Publications
- Open Access
- 26 January 2026
- Published by MDPI AG in Medical Sciences Forum
- Vol. 41 (1) , 2
Bioinformatics Screening of Phenylpropanoids from Pyrostegia venusta in ER+ Breast Cancer
This study investigated the cytotoxic, antiproliferative, and molecular interaction profiles of the phenylpropanoids verbascoside and isoverbascoside from Pyrostegia venusta using in silico approaches. Computational predictions suggested differential cytotoxicity trends between tumor and non-tumor breast cell models compared with tamoxifen. QSAR analyses indicated antiproliferative potential, while docking studies revealed stable ligand–protein interactions with estrogen-related targets and PTEN. ADMET predictions suggested favorable metabolic characteristics, including limited CYP3A4 interaction. Overall, these results provide predictive insights that support further experimental investigation of these phenylpropanoids in ER+ breast cancer models.
- 26 January 2026
- Published by MDPI AG in Medical Sciences Forum
- Vol. 41 (1) , 2
Open AccessBioinformatics Screening of Phenylpropanoids from Pyrostegia venusta in ER+ Breast Cancer
This study investigated the cytotoxic, antiproliferative, and molecular interaction profiles of the phenylpropanoids verbascoside and isoverbascoside from Pyrostegia venusta using in silico approaches. Computational predictions suggested differential cytotoxicity trends between tumor and non-tumor breast cell models compared with tamoxifen. QSAR analyses indicated antiproliferative potential, while docking studies revealed stable ligand–protein interactions with estrogen-related targets and PTEN. ADMET predictions suggested favorable metabolic characteristics, including limited CYP3A4 interaction. Overall, these results provide predictive insights that support further experimental investigation of these phenylpropanoids in ER+ breast cancer models.